JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples